These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 136287)

  • 21. Proceedings: Sodium valproate (Epilim) and photosensitivity. A preliminary report.
    Herrick CE; Maheshwari MC
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51735
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: A controlled trial of sodium valproate in severe epilepsy.
    Richens A
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):428. PubMed ID: 51730
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: Sodium valproate (Epilim) in the treatment of intractable epilepsy, including some observations on blood levels.
    Scott DF; Lloyd MH; France M; Hamilton C; Cohne RD
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51736
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: Preliminary experience with sodium valproate.
    Ronthal M
    S Afr Med J; 1975 Jun; 49(27):1077. PubMed ID: 1098174
    [No Abstract]   [Full Text] [Related]  

  • 25. Sodium valproate and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Jul; 133():82. PubMed ID: 352469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy.
    Lance JW; Anthony M
    Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689
    [No Abstract]   [Full Text] [Related]  

  • 27. Sodium valproate (Epilim) in the treatment of refractory epilepsy.
    Lines DR
    N Z Med J; 1978 Jan; 87(603):9-12. PubMed ID: 347342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate in the treatment of levodopa-induced dyskinesia.
    Price PA; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):702-6. PubMed ID: 355601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled trial of sodium valproate in severe epilepsy.
    Richens A; Ahmad S
    Br Med J; 1975 Nov; 4(5991):255-6. PubMed ID: 1104059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sydenham's chorea treated with sodium valproate.
    Dhanaraj M; Panneer A; Srinivas K
    J Assoc Physicians India; 1984 Nov; 32(11):1002. PubMed ID: 6441797
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Valproate in the U.S.A.
    Finkel MJ
    Lancet; 1976 Jun; 1(7973):1353-4. PubMed ID: 58346
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 33. Early experience with sodium valproate.
    Ronthal M; Terespolsky PS
    S Afr Med J; 1976 Nov; 50(50):1997-8. PubMed ID: 827029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of sodium dipropylacetate in the treatment of parkinsonian tremor. Preliminary note].
    Piccinin GL; Morocutti C; Urciuoli R; Bernardi G
    Clin Ter; 1977 Jul; 82(1):25-30. PubMed ID: 332440
    [No Abstract]   [Full Text] [Related]  

  • 35. Valproate and GABAergic system effects.
    Winterer G
    Neuropsychopharmacology; 2003 Nov; 28(11):2050-1. PubMed ID: 14574363
    [No Abstract]   [Full Text] [Related]  

  • 36. GABA and movement disorders.
    Marsden CD; Sheehy MP
    Adv Biochem Psychopharmacol; 1981; 30():225-34. PubMed ID: 6460427
    [No Abstract]   [Full Text] [Related]  

  • 37. [Good effect of valproate against aggression in Huntington disease. Only two cases reported earlier].
    Rask G; Andersson C
    Lakartidningen; 2010 Dec 1-7; 107(48):3060-1. PubMed ID: 21287753
    [No Abstract]   [Full Text] [Related]  

  • 38. Post-anoxic action myoclonus: improvement with valproic acid.
    Fahn S
    N Engl J Med; 1978 Aug; 299(6):313-4. PubMed ID: 351404
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement of Huntington's disease with olanzapine and valproate.
    Grove VE; Quintanilla J; DeVaney GT
    N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330
    [No Abstract]   [Full Text] [Related]  

  • 40. Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.
    Tomlinson EB
    Proc Aust Assoc Neurol; 1974; 11():203-8. PubMed ID: 4620029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.